Your browser doesn't support javascript.
loading
International practices in the dietary management of fructose 1-6 biphosphatase deficiency.
Pinto, A; Alfadhel, M; Akroyd, R; Atik Altinok, Y; Bernabei, S M; Bernstein, L; Bruni, G; Caine, G; Cameron, E; Carruthers, R; Cochrane, B; Daly, A; de Boer, F; Delaunay, S; Dianin, A; Dixon, M; Drogari, E; Dubois, S; Evans, S; Gribben, J; Gugelmo, G; Heidenborg, C; Hunjan, I; Kok, I L; Kumru, B; Liguori, A; Mayr, D; Megdad, E; Meyer, U; Oliveira, R B; Pal, A; Pozzoli, A; Pretese, R; Rocha, J C; Rosenbaum-Fabian, S; Serrano-Nieto, J; Sjoqvist, E; Timmer, C; White, L; van den Hurk, T; van Rijn, M; Zweers, H; Ziadlou, M; MacDonald, A.
Afiliación
  • Pinto A; Birmingham Women's and Children's Hospital, Birmingham, UK. alex.pinto@nhs.net.
  • Alfadhel M; King Abdullah International Medical Research Centre, King Saud bin Abdulaziz University for Health Sciences, Genetic Division, Department of Pediatrics, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia.
  • Akroyd R; National Metabolic Service, Starship Child Health and Auckland City Hospital, Auckland, New Zealand.
  • Atik Altinok Y; Pediatric Metabolism Department, Ege University Medical Faculty, Izmir, Turkey.
  • Bernabei SM; Children's Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Bernstein L; IMD Nutrition, Children's Hospital Colorado, Aurora, CO, USA.
  • Bruni G; Azienda Ospedaliero Universitaria Meyer, Florence, Italy.
  • Caine G; Mid Yorks NHS Trust, Yorkshire, UK.
  • Cameron E; Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Carruthers R; Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK.
  • Cochrane B; Royal Hospital for Children, Glasgow, Scotland, UK.
  • Daly A; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • de Boer F; Division of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, PO BOX 30.001, 9700 RB, Groningen, The Netherlands.
  • Delaunay S; Centre hospitalier Universitaire de Rennes, Rennes, France.
  • Dianin A; Department of Pediatrics, Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, University Hospital of Verona, Verona, Italy.
  • Dixon M; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Drogari E; Unit of Metabolic Diseases, Choremio Research Laboratory, 1st Department of Paediatrics, University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Dubois S; Centre de référence des maladies héréditaires du métabolisme, Hôpital Necker Enfants Malades, Paris, France.
  • Evans S; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Gribben J; Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Gugelmo G; Department of Pediatrics, Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, University Hospital of Verona, Verona, Italy.
  • Heidenborg C; Karolinska University Hospital, Stockholm, Sweden.
  • Hunjan I; Bradford Teaching Hospital NHS Foundation Trust, Bradford, UK.
  • Kok IL; Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Kumru B; Department of Nutrition and Diet, Gaziantep Cengiz Gökçek Obstetrics and Pediatric Hospital, Gaziantep, Turkey.
  • Liguori A; Children's Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Mayr D; Ernährungsmedizinische Beratung, Universitätsklinik für Kinder- und Jugendheilkunde, Salzburg, Austria.
  • Megdad E; Metabolic Nutrition Clinics. King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Meyer U; Clinic of Paediatric Kidney, Liver and Metabolic Diseases, Medical School Hannover, Hannover, Germany.
  • Oliveira RB; Centro de Referência em Erros Inatos do Metabolismo, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Pal A; Akademiska children's hospital, Uppsala, Sweden.
  • Pozzoli A; Guglielmo Da Saliceto's Hospital, Piacenza, Italy.
  • Pretese R; Fondazione MBBM, San Gerardo Hospital, Monza, Italy.
  • Rocha JC; Centro de Referência de Doenças Hereditárias do Metabolismo, Centro Hospitalar do Porto - CHP, Porto, Portugal.
  • Rosenbaum-Fabian S; Centro de Genética Médica, Centro Hospitalar do Porto (CHP), Porto, Portugal.
  • Serrano-Nieto J; Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Porto, Portugal.
  • Sjoqvist E; Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal.
  • Timmer C; University Children's Hospital Freiburg, Freiburg, Germany.
  • White L; Hospital Regional Universitario Málaga, Málaga, Spain.
  • van den Hurk T; Children's Hospital, University Hospital, Lund, Sweden.
  • van Rijn M; Academic Medical Center Amsterdam, Amsterdam, Netherlands.
  • Zweers H; Sheffield Children's Hospital, Sheffield, UK.
  • Ziadlou M; Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • MacDonald A; Division of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, PO BOX 30.001, 9700 RB, Groningen, The Netherlands.
Orphanet J Rare Dis ; 13(1): 21, 2018 01 25.
Article en En | MEDLINE | ID: mdl-29370874
ABSTRACT

BACKGROUND:

In fructose 1,6 bisphosphatase (FBPase) deficiency, management aims to prevent hypoglycaemia and lactic acidosis by avoiding prolonged fasting, particularly during febrile illness. Although the need for an emergency regimen to avoid metabolic decompensation is well established at times of illness, there is uncertainty about the need for other dietary management strategies such as sucrose or fructose restriction. We assessed international differences in the dietary management of FBPase deficiency.

METHODS:

A cross-sectional questionnaire (13 questions) was emailed to all members of the Society for the Study of Inborn Errors of Metabolism (SSIEM) and a wide database of inherited metabolic disorder dietitians.

RESULTS:

Thirty-six centres reported the dietary prescriptions of 126 patients with FBPase deficiency. Patients' age at questionnaire completion was 1-10y, 46% (n = 58), 11-16y, 21% (n = 27), and >16y, 33% (n = 41). Diagnostic age was <1y, 36% (n = 46); 1-10y, 59% (n = 74); 11-16y, 3% (n = 4); and >16y, 2% (n = 2). Seventy-five per cent of centres advocated dietary restrictions. This included restriction of high sucrose foods only (n = 7 centres, 19%); fruit and sugary foods (n = 4, 11%); fruit, vegetables and sugary foods (n = 13, 36%). Twenty-five per cent of centres (n = 9), advised no dietary restrictions when patients were well. A higher percentage of patients aged >16y rather than ≤16y were prescribed dietary restrictions patients aged 1-10y, 67% (n = 39/58), 11-16y, 63% (n = 17/27) and >16y, 85% (n = 35/41). Patients classified as having a normal fasting tolerance increased with age from 30% in 1-10y, to 36% in 11-16y, and 58% in >16y, but it was unclear if fasting tolerance was biochemically proven. Twenty centres (56%) routinely prescribed uncooked cornstarch (UCCS) to limit overnight fasting in 47 patients regardless of their actual fasting tolerance (37%). All centres advocated an emergency regimen mainly based on glucose polymer for illness management.

CONCLUSIONS:

Although all patients were prescribed an emergency regimen for illness, use of sucrose and fructose restricted diets with UCCS supplementation varied widely. Restrictions did not relax with age. International guidelines are necessary to help direct future dietary management of FBPase deficiency.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Deficiencia de Fructosa-1,6-Difosfatasa Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Orphanet J Rare Dis Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Deficiencia de Fructosa-1,6-Difosfatasa Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Orphanet J Rare Dis Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido